Author:
Geisenberger Christoph,Mock Andreas,Warta Rolf,Rapp Carmen,Schwager Christian,Korshunov Andrey,Nied Ann-Katrin,Capper David,Brors Benedikt,Jungk Christine,Jones David,Collins V. Peter,Ichimura Koichi,Bäcklund L. Magnus,Schnabel Elena,Mittelbron Michel,Lahrmann Bernd,Zheng Siyuan,Verhaak Roel G. W.,Grabe Niels,Pfister Stefan M.,Hartmann Christian,von Deimling Andreas,Debus Jürgen,Unterberg Andreas,Abdollahi Amir,Herold-Mende Christel
Funder
Anni Hofmann Stiftung
German Federal Ministry of Research and Education (BMBF)
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Neurology (clinical),Pathology and Forensic Medicine
Reference59 articles.
1. Alvarez S, MacGrogan D, Calasanz MJ, Nimer SD, Jhanwar SC (2001) Frequent gain of chromosome 19 in megakaryoblastic leukemias detected by comparative genomic hybridization. Genes Chromosom Cancer 32:285–293
2. Brennan CW, Verhaak RGW, McKenna A, Campos B, Noushmehr H, Salama SR et al (2013) The somatic genomic landscape of glioblastoma. Cell 155:462–477
3. Burton EC, Lamborn KR, Feuerstein BG, Prados M, Scott J, Forsyth P et al (2002) Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma. Cancer Res 62:6205–6210
4. Burton EC, Lamborn KR, Forsyth P, Scott J, O’Campo J, Uyehara-Lock J et al (2002) Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors. Clin Cancer Res 8:180–187
5. Capper D, Zentgraf H, Balss J, Hartmann C, Von Deimling A (2009) Monoclonal antibody specific for IDH1 R132H mutation. Acta Neuropathol 118:599–601